CCSD code F4430 – Partial parotidectomy with facial nerve preservation

Key takeaways

CCSD code F4430 covers partial excision of the parotid gland with the facial nerve identified and preserved, and the operative note must confirm both.

Total parotid excision with the nerve preserved is F4410, and other parotid excision, including nerve sacrifice, falls under F4400.

Pleomorphic adenoma accounts for about 70% of benign parotid tumors and is the most common indication for F4430.

Missing pre-authorization is the most common reason UK insurers deny F4430 claims, so obtain it before the procedure.

Practice management software such as Pabau keeps the operative note, forms and insurer invoices in one patient record, so F4430 claims are easier to defend.

CCSD code F4430: Definition and official descriptor

CCSD code F4430 is the code for a partial or superficial parotidectomy. Its official descriptor is “Partial excision of parotid gland and preservation of facial nerve.” Both parts of that descriptor carry equal billing weight. The resection must be partial, leaving part of the gland in situ. The facial nerve must also be identified, mapped and preserved throughout.

A claim whose operative note doesn’t explicitly confirm both elements is vulnerable to denial on audit. F4430 is a consultant surgeon code, and it covers the principal surgical procedure only. Anesthetic fees, assistant surgeon fees and intraoperative monitoring are billed separately, under their own CCSD codes or as agreed add-ons, depending on the insurer’s policy.

The procedure: What partial excision of the parotid gland involves

Partial parotidectomy with facial nerve preservation is a major ENT or maxillofacial operation, typically performed under general anesthesia. The standard approach uses a modified Blair or facelift incision, followed by dissection through the parotid fascia.

The surgeon then identifies the facial nerve trunk at the stylomastoid foramen. Its branches are traced and protected while the superficial lobe or affected portion is resected around the tumor with an adequate margin.

These intraoperative steps make the procedure codeable as F4430 rather than a simpler or more radical alternative:

• Formal identification of the main facial nerve trunk before any glandular dissection
• Systematic mapping and preservation of all facial nerve branches (temporal, zygomatic, buccal, marginal mandibular, cervical)
• Partial removal only, with residual parotid tissue left in situ
• Specimen sent for histological examination
• Drain placement and layered wound closure

Many centers use intraoperative facial nerve monitoring (IONM), typically continuous electromyography, as an adjunct. Its billing status is covered in the additional codes section below.

Clinical indications: When is F4430 used?

F4430 is used when a discrete parotid lesion needs surgical removal and the disease doesn’t warrant total excision or nerve sacrifice. Insurers expect the clinical indication to be documented clearly in the pre-authorization request and in the operative note.

Accepted indications that support an F4430 claim include:

• Pleomorphic adenoma (benign mixed tumor): The most common indication, accounting for roughly 70% of benign parotid tumors. Its pseudocapsule makes adequate marginal excision essential. That’s why partial parotidectomy with nerve preservation is the standard of care, rather than enucleation.
• Warthin’s tumor (cystadenolymphoma): The second most common benign parotid neoplasm, and often bilateral. Partial excision is appropriate when the lesion is confined to one lobe.
• Other benign parotid neoplasms: Basal cell adenoma, oncocytoma and other discrete benign masses where nerve sacrifice isn’t required.
• Low-grade malignancy in selected cases: Some low-grade mucoepidermoid or acinic cell carcinomas, where partial resection can achieve clear margins and preserve nerve function. These need explicit documentation of stage and surgical intent.

F4430 is not appropriate for diffuse gland involvement, high-grade malignancy requiring nerve sacrifice, or recurrent disease where total excision is planned. Code F4410 if the entire gland was removed with the nerve preserved. Use F4400 for other parotid excision, for example when the nerve was sacrificed.

Adjacent CCSD codes: Choosing between F4400, F4410 and F4430

The salivary gland codes F4400–F4450 sit together in the CCSD schedule, but only F4400, F4410 and F4430 cover parotid excision. F4440 and F4450 are for the submandibular and sublingual glands. Picking the wrong code from this group is the second most common billing error after missing pre-authorization.

The table below sets out the key distinctions, including the biopsy codes that are sometimes confused with F4430. Every neighboring code is listed in the CCSD codes directory.

The boundary between F4430 and F4410 depends on the scope of resection documented in the operative note, not on the surgeon’s intent. If the note states the entire parotid gland was removed, the code is F4410 whatever the surgeon’s framing. F4430 also can’t be used when the nerve was sacrificed, because that case falls under F4400.

The chart below turns those rules into three questions you can answer from the operative note before you submit.

OPCS-4 equivalent and cross-referencing with NHS coding

The NHS classifies procedures with OPCS-4 rather than CCSD. Surgeons who work in both NHS and private settings need to know how the two systems relate. It matters most when they share operative reports or write summary letters that quote procedure codes.

The OPCS-4 equivalent of CCSD F4430 is F44.2 (partial excision of parotid gland). The NHS Classifications Browser holds the current OPCS-4 code set, so you can verify F44.2 against the live schedule.

The two systems don’t map one-to-one. OPCS-4 codes feed NHS episode data, such as Hospital Episode Statistics (HES) returns and Payment by Results (PbR) tariff allocation. CCSD codes are used only for private insurer billing and reimbursement.

• CCSD F4430: Submit it to private medical insurers (Bupa, AXA Health, Aviva, Cigna, Vitality, WPA, Healix, Allianz Care) for privately funded partial parotidectomy.
• OPCS-4 F44.2: Recorded in the NHS procedure data set for NHS-funded episodes, and shown in discharge summaries and HES datasets.
• Never mix systems: A private insurer automatically rejects a claim that carries an OPCS code. CCSD codes shouldn’t appear in NHS episode data submissions either.

If you bill across NHS and private settings, confirm which system applies to the episode before coding. Private self-pay patients are billed under CCSD, even when the procedure takes place in an NHS facility under a private patient arrangement. Getting this right from the first private list prevents systematic coding errors later.

Documentation requirements for F4430 claims

An F4430 claim without a compliant operative note won’t survive insurer audit. UK private medical insurers have tightened documentation requirements in recent years. For partial parotidectomy, the operative note is the primary evidence that the correct code was used.

To support an F4430 claim, the operative note must include:

• Confirmation of partial resection: An explicit statement that part of the parotid gland was left in situ. Phrases such as “superficial lobe removed, deep lobe preserved” or “partial parotidectomy performed with residual gland intact” are acceptable.
• Facial nerve identification and preservation: The note must state that the nerve trunk was identified at the stylomastoid foramen. It must also confirm every branch was traced and preserved. A vague reference to “nerve care taken” is insufficient.
• Tumor details: Size, anatomical location within the gland (superficial lobe, deep lobe, tail) and macroscopic appearance.
• Histology submission: Confirmation that the specimen was sent for histological examination, including specimen labeling and orientation.
• Surgeon identification: The operating surgeon’s name and General Medical Council (GMC) registration number.
• Pre-operative imaging referenced: The imaging modality used (ultrasound, MRI or CT) and its date, in the note or the pre-operative documentation.

In Pabau, the practice management platform we build, the operative note sits in the same patient record as the consent forms and the insurer invoice. A note template that lists each element above helps the surgeon complete it before the claim goes out. With the note beside the invoice, audit-ready claims management becomes part of the routine.

Pre-authorization: What UK insurers require before approving F4430

Failing to obtain pre-authorization before the procedure is the most common reason F4430 claims are denied. Every major UK private medical insurer requires pre-authorization for parotid surgery. It doesn’t guarantee payment, but proceeding without it almost always guarantees denial.

The standard pre-authorization pack for F4430 across major insurers includes:

• GP referral letter confirming the clinical indication
• Consultant assessment letter recommending surgery, including clinical findings and the proposed procedure
• Imaging report (ultrasound, MRI or CT of the parotid region) confirming the lesion
• ICD-10 diagnosis code (e.g. D11.0 for benign neoplasm of the parotid gland, or the relevant malignancy code)
• CCSD procedure code F4430 and the anticipated admission type (day case or inpatient)

A malignant parotid lesion is coded under ICD-10 C07 instead. The diagnosis on the pre-authorization request should match the cytology or biopsy findings, or the insurer may query the claim later.

Each insurer adds its own rules. Bupa’s code search portal lets consultants verify recognition and fee levels before submission. AXA Health’s specialist procedure portal gives chapter-level fee information and any pre-authorization rules for F44xx parotid codes.

Both portals update annually, so check the current policy year’s requirements rather than relying on prior-year guidance. The Bupa CCSD code reference covers recognition, billing rules and submission requirements in detail.

Aviva, Cigna and Vitality Health follow broadly similar pre-authorization requirements, but they set different time limits for submitting claims after the procedure. Aviva typically requires claims within 90 days of the procedure date, while Cigna and Vitality vary by policy. Confirm submission deadlines with the insurer at the point of pre-authorization.

Fee benchmarks and CCSD schedule rates for F4430

The CCSD schedule publishes indicative fee levels for each code. Contracted rates between individual consultants and insurers may differ, and some insurers run fixed-fee arrangements that supersede the published schedule. The table below reflects indicative CCSD benchmarks, so verify it against the current schedule year and your insurer contracts.

The Aviva fee schedule publishes procedure-level rates and is a useful cross-reference for current CCSD benchmarks. Payment depends on the consultant’s recognition status with each insurer and any agreed individual contracts. Consultants without direct recognition from an insurer may receive reduced or nil reimbursement, whatever the schedule rate.

Additional codes that can be billed alongside F4430

Several adjunct services around partial parotidectomy may be billable on top of F4430, depending on insurer policy and the clinical scenario. Most aren’t included in the F4430 fee. Each needs its own claim and, in some cases, separate pre-authorization.

• Intraoperative facial nerve monitoring (IONM): The CCSD schedule includes a code for intraoperative neurophysiological monitoring. Whether IONM is billable separately or bundled into the surgical fee varies by insurer and policy year. Verify current bundling status with the specific insurer before billing IONM separately. Some insurers require explicit pre-authorization for IONM, and others won’t fund it at all.
• Histopathology: The pathology laboratory typically bills specimen analysis directly, under the relevant pathology code. It isn’t included in the F4430 surgical fee.
• Post-operative ultrasound: Surveillance imaging after parotidectomy may be billed under the relevant imaging code if it’s clinically indicated and pre-authorized.
• Second surgeon fee: A second consultant who actively assists, such as a neurophysiologist or a second ENT surgeon, may bill their fee separately. That depends on the insurer accepting the clinical justification.

Confirm current bundling rules with each insurer before submitting add-on codes alongside F4430. Bundling policies change between policy years and differ materially between Bupa, AXA Health, Aviva and the smaller private medical insurers.

Common claim denials for F4430 and how to avoid them

F4430 claims are denied for predictable, avoidable reasons. Here are the most common denial triggers and the fix for each.

A complete audit trail strengthens your position when you appeal a denial. Record the pre-authorization reference number, the date, and the name of the insurer representative who granted approval. Saved against the patient record, those details are on hand the moment a claim is challenged.

Parotid biopsy vs partial parotidectomy: Avoiding code confusion

Billing staff sometimes confuse the biopsy codes F4640 and F4810 with F4430. It happens most when the operative intent changes intraoperatively, or when diagnostic and therapeutic procedures are performed in the same episode.

The scope of resection documented in the operative note decides between them:

• F4640 or F4810 applies when: The procedure is a diagnostic needle aspiration of the parotid (F4640) or an open salivary lesion biopsy (F4810). The parotid gland itself isn’t excised. If the pathology report describes a tissue sample rather than a tumor specimen with margins, the procedure is a biopsy.
• F4430 applies when: A portion of the gland containing a tumor is excised with a margin, and the facial nerve is identified and preserved. The specimen is a glandular segment, not an aspirate or a biopsy fragment.

Submitting F4430 for a procedure that was a diagnostic biopsy is upcoding. It carries significant consequences under GMC conduct rules and insurer fraud policies. A note can occasionally describe a biopsy and a therapeutic excision in the same session. In that case, ask the insurer for coding guidance before submitting.

How Pabau supports CCSD billing for parotid surgery

An F4430 claim passes through several hands before it’s paid. The surgeon writes the operative note, a secretary chases pre-authorization, and the billing team codes and submits the invoice. When those steps live in separate inboxes and spreadsheets, a missing nerve-preservation line or an expired authorization surfaces only after the denial.

Pabau brings that work into one system. The operative note, consent forms and insurer invoice sit in the same patient record. Your billing team can check the note against the code before the claim goes out, without asking the surgeon for a copy.

• Clinical note templates: Build the operative note around what insurers check, such as resection scope, facial nerve findings and histology, so each note arrives complete.
• Insurer invoices in the patient record: Bupa and AXA Health invoices are raised against the same record as the note. The code on the claim then matches the documented procedure.
• Payment tracking: Insurer remittances are matched against each invoice, so you can see which F4430 claims are paid, unpaid or reissued.
• Evidence ready for appeals: Notes, forms and invoices stay together, so the appeal paperwork is already in one place when a claim is challenged.

For surgical practices with a steady private parotid caseload, that means less time reworking denied claims and more time with patients.

Spend less time chasing CCSD claims

Pabau keeps operative notes, consent forms and insurer invoices in one patient record for UK private ENT and surgical practices. Your billing team spends less time chasing claims and more time getting paid.

Book a demo

Conclusion

F4430 is one of the easier parotid codes to defend, as long as the operative note does the work. If the note says part of the gland stayed and the facial nerve was preserved, the code holds. If the note is vague, the claim is exposed, whatever the surgeon intended.

So make the note template and the pre-authorization pack two checks that every parotid booking passes. Once they’re routine, F4430 denials get far less frequent, and an appeal means attaching paperwork you already hold.

Want the operative note, the forms and the insurer invoice in one record? Book a demo to see how Pabau handles CCSD billing for private surgical practices.

Continue your research

Billing a parotid procedure to Bupa? Bupa CCSD procedure code guide covers recognition rules, bundling restrictions and submission requirements for Bupa-specific billing.

Was the nerve sacrificed? CCSD code F4400: Parotid gland excision billing guide explains when other parotid excision falls outside F4410 and F4430.

Only a biopsy taken? CCSD code F4810: Open salivary gland biopsy billing guide covers the documentation an open biopsy claim needs.

Coding a malignant parotid lesion? ICD-10 code C07: Malignant neoplasm of parotid gland sets out the diagnosis code to pair with parotid surgery.

Working on the parotid duct instead? CCSD code F5010: Parotid duct transposition billing guide covers the code for repositioning the duct rather than excising the gland.

Frequently asked questions